Literature DB >> 16557362

Gene-dosage effect on chromosome 21 transcriptome in trisomy 21: implication in Down syndrome cognitive disorders.

Pascal Kahlem1.   

Abstract

In the era of human functional genomics, the chromosome 21 has represented a prototype for pioneering global biotechnologies. Its relatively low gene content enabled studying Down syndrome at the chromosomal scale, for which the last years have seen intense research activity aiming at genotype-phenotype correlations. The global gene-dose dependent upregulation of gene expression seen in the context of trisomy and preliminary functional annotation of chromosome 21 genes points towards candidate genes and molecular pathways potentially associated with the cognitive defects observed in Down syndrome.

Entities:  

Mesh:

Year:  2006        PMID: 16557362     DOI: 10.1007/s10519-006-9053-z

Source DB:  PubMed          Journal:  Behav Genet        ISSN: 0001-8244            Impact factor:   2.805


  8 in total

1.  Trisomy-21 gene dosage over-expression of miRNAs results in the haploinsufficiency of specific target proteins.

Authors:  Terry S Elton; Sarah E Sansom; Mickey M Martin
Journal:  RNA Biol       Date:  2010-09-01       Impact factor: 4.652

2.  Spatial organization of chromosome territories in the interphase nucleus of trisomy 21 cells.

Authors:  Stephan Kemeny; Christophe Tatout; Gaelle Salaun; Céline Pebrel-Richard; Carole Goumy; Natasha Ollier; Eugenie Maurin; Bruno Pereira; Philippe Vago; Laetitia Gouas
Journal:  Chromosoma       Date:  2017-12-14       Impact factor: 4.316

3.  Chromosome 21-derived microRNAs provide an etiological basis for aberrant protein expression in human Down syndrome brains.

Authors:  Donald E Kuhn; Gerard J Nuovo; Alvin V Terry; Mickey M Martin; Geraldine E Malana; Sarah E Sansom; Adam P Pleister; Wayne D Beck; Elizabeth Head; David S Feldman; Terry S Elton
Journal:  J Biol Chem       Date:  2009-11-06       Impact factor: 5.157

4.  Integrated Quantitative Neuro-Transcriptome Analysis of Several Brain Areas in Human Trisomy 21.

Authors:  Alejandra Rodríguez-Ortiz; Julio César Montoya-Villegas; Felipe García-Vallejo; Yecid Mina-Paz
Journal:  Genes (Basel)       Date:  2022-04-01       Impact factor: 4.141

5.  A Pair of Maternal Chromosomes Derived from Meiotic Nondisjunction in Trisomy 21 Affects Nuclear Architecture and Transcriptional Regulation.

Authors:  Sayaka Omori; Hideyuki Tanabe; Kimihiko Banno; Ayumi Tsuji; Nobutoshi Nawa; Katsuya Hirata; Keiji Kawatani; Chikara Kokubu; Junji Takeda; Hidetoshi Taniguchi; Hitomi Arahori; Kazuko Wada; Yasuji Kitabatake; Keiichi Ozono
Journal:  Sci Rep       Date:  2017-04-10       Impact factor: 4.379

6.  Genome-wide miRNA profiling in plasma of pregnant women with down syndrome fetuses.

Authors:  Iveta Zedníková; Blanka Chylíková; Ondřej Šeda; Marie Korabečná; Eva Pazourková; Miroslav Břešťák; Miroslava Krkavcová; Pavel Calda; Aleš Hořínek
Journal:  Mol Biol Rep       Date:  2020-05-30       Impact factor: 2.316

7.  Downregulated Wnt/β-catenin signalling in the Down syndrome hippocampus.

Authors:  Simone Granno; Jonathon Nixon-Abell; Daniel C Berwick; Justin Tosh; George Heaton; Sultan Almudimeegh; Zenisha Nagda; Jean-Christophe Rain; Manuela Zanda; Vincent Plagnol; Victor L J Tybulewicz; Karen Cleverley; Frances K Wiseman; Elizabeth M C Fisher; Kirsten Harvey
Journal:  Sci Rep       Date:  2019-05-13       Impact factor: 4.379

8.  Positional gene enrichment analysis of gene sets for high-resolution identification of overrepresented chromosomal regions.

Authors:  Katleen De Preter; Roland Barriot; Frank Speleman; Jo Vandesompele; Yves Moreau
Journal:  Nucleic Acids Res       Date:  2008-03-16       Impact factor: 16.971

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.